$26.67
-0.80-2.91%
Last update: Nov 5, 4:00 PM

Market sentiment signals for Avalyn Pharma (AVLN): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
4 analysts
Options Flow (P/C)
0.41
More calls — Bullish
Avg Consensus PT
$62
+132.5%
Highest Price Target
$80
+200.0%
Lowest Price Target
$51
+91.2%
Short Interest
5.3%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Raymond James | Tiago Fauth— | +125.0% | $60 | Initiate | Outperform |
| Aug 13, 2026 | Morgan Stanley | Judah Frommer— | +113.7% | $53 → $57 | Maintained | Overweight |